The value of Safflower Yellow Injection for the treatment of acute cerebral infarction: A randomized controlled trial

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Li, Le Jun ^a,b   Li, Yu Mei ^a   Qiao, Ben Yu ^a   Jiang, Shan ^a   Li, Xin ^a   Du, Hong Ming ^c   Han, Peng Cheng ^b   Shi, Jiong ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c Changchun Sanzhen Industrial Limited Company   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PIRACETAM; PLACEBO; SAFFLOWER EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SAFFLOWER; SCORING SYSTEM; SINGLE BLIND PROCEDURE;

EID: 84930636464     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/478793     Document Type: Article

References (25)

1. C. D. Mathers and D. Loncar, "Projections of global mortality and burden of disease from 2002 to 2030," PLoS Medicine, vol. 3, no. 11, article e442, 2006.
2. C. D. A. Wolfe, "The impact of stroke," British Medical Bulletin, vol. 56, no. 2, pp. 275-286, 2000.
3. Z. F. Yang, Q. B. Mei, and Y. P. Jiang, "The efective components and pharmacological efects of safower," Xi Bei Yao Xue Za Zhi, vol. 16, no. 2, pp. 131-133, 2001 (Chinese).
4. S. Fan, N. Lin, G. Shan, P. Zuo, and L. Cui, "Safower yellow for acute ischemic stroke: a systematic review of randomized controlled trials," Complementary Terapies in Medicine, vol. 22, no. 2, pp. 354-361, 2014.
5. B.-X. Zang, M. Jin, N. Si, Y. Zhang, W. Wu, and Y.-Z. Piao, "Antagonistic efect of hydroxysafor yellow a on the platelet activating factor receptor," Yaoxue Xuebao, vol. 37, no. 9, pp. 696-699, 2002 (Chinese).
6. H. B. Zhu, L. Zhang, Z. H. Wang et al., "Terapeutic efects of hydroxysafor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms," Journal of Asian Natural Products Research, vol. 7, no. 4, pp. 607-613, 2005.
7. X. Sun, X. Wei, S. Qu, Y. Zhao, and X. Zhang, "Hydroxysafor yellow A suppresses thrombin generation and infammatory responses following focal cerebral ischemia-reperfusion in rats," Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 14, pp. 4120-4124, 2010.
8. L. Sun, L. Yang, Y.-W. Xu et al., "Neuroprotection of hydrox-ysafor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and bloodbrain barrier disruption," Brain Research, vol. 1473, no. 9, pp. 227-235, 2012.
9. S.-Y. Ye and W.-Y. Gao, "Hydroxysafor yellow a protects neuron against hypoxia injury and suppresses infammatory responses following focal ischemia reperfusion in rats," Archives of Pharmacal Research, vol. 31, no. 8, pp. 1010-1015, 2008.
10. J.-W. Tian, F.-H. Fu, W.-L. Jiang, C.-Y. Wang, F. Sun, and T.-P. Zhang, "Protective efect of hydroxysafor yellow A against rat cortex mitochondrial injuries induced by cerebral ischemia," Yaoxue Xuebao, vol. 39, no. 10, pp. 774-777, 2004 (Chinese).
11. Z. L. Ma, B. X. Wu, D. M. Cheng et al., "Clinic observation of the curative efect of safr yellow in the treatment of acute cerebral infarction," Chinese Journal of Practical Nervous Disease, vol. 14, no. 24, pp. 30-31, 2011 (Chinese).
12. B. Ye, W. J. Li, L. Zheng, and R. Liu, "Efect of safower yellow pigment on blood rheology and cerebral hemodynamics in patients with acute cerebral infarction," Chinese Journal of General Practice, vol. 10, no. 2, pp. 219-221, 2012 (Chinese).
13. B. Wu, M. Liu, H. Liu et al., "Meta-analysis of traditional Chinese patent medicine for ischemic stroke," Stroke, vol. 38, no. 6, pp. 1973-1979, 2007.
14. Chinese Neuroscience Society and Chinese Neurosurgical Society, "Diagnostic criteria of various types of cerebrovascular disease," Zhong Hua Shen Jing Ke Za Zhi, vol. 29, no. 6, pp. 89-90, 1996 (Chinese).
15. J. Wu, J. P. Jia, and L. Y. Cui, Neurology, People's Health Publishing Company, Beijing, China, 2005, (Chinese).
16. L. B. Goldstein and G. P. Samsa, "Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial," Stroke, vol. 28, no. 2, pp. 307-310, 1997.
17. 2, aspirin dose, and vascular events in blacks afer recent cerebral infarction," Stroke, vol. 35, no. 3, pp. 727-730, 2004.
18. I. Velcheva, E. Titianova, and N. Antonova, "Evaluation of the hemorheological and neurosonographic relationship in patients with cerebrovascular diseases," Clinical Hemorheology and Microcirculation, vol. 30, no. 3-4, pp. 373-380, 2004.
19. W. Wu, M. Jin, and S. D. Yang, "Safower yellow inhibition of platelet-activating factor due to the proliferation of capillary permeability," Cardiopulmonary Disease Journal, vol. 18, no. 4, pp. 281-283, 1999.
20. W. M. Kuebler, Y. Yang, R. Samapati, and S. Uhlig, "Vascular barrier regulation by PAF, ceramide, caveolae, and NO-an intricate signaling network with discrepant efects in the pulmonary and systemic vasculature," Cellular Physiology and Biochemistry, vol. 26, no. 1, pp. 29-40, 2010.
21. J. W. Li, "Safower yellow plasminogen activator inhibiting agents dose levels in rabbit," Chinese Herbal Medicine, vol. 30, no. 2, pp. 128-129, 1999 (Chinese).
22. T. Sairanen, O. Carpén, M.-L. Karjalainen-Lindsberg et al., "Evolution of cerebral tumor necrosis factor-α production during human ischemic stroke," Stroke, vol. 32, no. 8, pp. 1750-1757, 2001.
23. H. S. Han and M. A. Yenari, "Cellular targets of brain infam-mation in stroke," Current Opinion in Investigational Drugs, vol. 4, no. 5, pp. 522-529, 2003.
24. A. Durukan and T. Tatlisumak, "Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia," Pharmacology Biochemistry and Behavior, vol. 87, no. 1, pp. 179-197, 2007.
25. S. M. Allan and N. J. Rothwell, "Cytokines and acute neurode-generation," Nature Reviews Neuroscience, vol. 2, no. 10, pp. 734-744, 2001.